...
首页> 外文期刊>Bioconjugate Chemistry >Mixed-Ligand Technetium(III)Complexes with Tetradendate/monodendate NS_3/Isocyanide Coordiantion:A New Nonpolar Technetium System for the Design of Neutral and Lipophilic Complexes Stable in Vivo
【24h】

Mixed-Ligand Technetium(III)Complexes with Tetradendate/monodendate NS_3/Isocyanide Coordiantion:A New Nonpolar Technetium System for the Design of Neutral and Lipophilic Complexes Stable in Vivo

机译:四氢萘磺酸盐/单价磺酸盐NS_3 /异氰化物配位的混合配体III(III)配合物:一种新型的用于体内稳定的中性和亲脂性配合物设计的非极性System系统

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Starting from the tripodal ligand 2,2’,2”-nitrilotris(ethanethiol) (NS3) and isocyanides (CNR) as co-ligands, neutral mixed-ligand technetium(III) complexes of the general formulation [Tc(N53)(CNR)] have been synthesized and characterized. The ~(99)Tc complexes can be obtained by a two-step reduction/substitution procedure starting from [TcO_4] - via the phosphine-containing precursor complex [Tc-(NS_3)(PMe_2Ph)]. As shown by X-ray structural analyses, the complexes adopt a nearly ideal trigonal-bipyramidal geometry with the trigonal plane formed by the three thiolate sulfurs of the tripodal ligand. The central nitrogen atom of the chelate ligand and the monodendate isocyanides occupy the apical positions. The no-carrier-added preparation of the corresponding uumTc complexes was performed by a one-step procedure starting from ~(99m)[TcO_4]~- with stannous chloride as reducing agent. Biodistribution studies in the rat demonstrated for the nonpolar, lipophilic compounds a significant initial brain uptake. In vitro challenge experiments with glutathione clearly indicated that no transchelation reaction occurs. Furthermore, there were no indications for reoxidation of Tc(III) to Tc(V) species or pertechnetate. We propose this type of complexes as a useful tool in the design of lipophilic ~(99)m Tc or ~(186)Re radiopharmaceuticals.
机译:从三脚架配体2,2',2”-硝腈(乙硫醇)(NS3)和异氰化物(CNR)作为共配体,一般配方为[Tc(N53)(CNR)的中性混合配体tech(III)配合物)]已合成并表征。 〜(99)Tc络合物可通过两步还原/取代过程从[TcO_4]-经由含膦的前体络合物[Tc-(NS_3)(PMe_2Ph)]获得。如X射线结构分析所示,该络合物采用接近理想的三角-双锥体几何结构,其三角平面由三脚架配体的三种硫醇盐硫形成。螯合配体的中心氮原子和单树酯异氰化物占据顶部位置。从〜(99m)[TcO_4]〜-开始,以氯化亚锡为还原剂,通过一步步骤进行相应的uumTc复合物的无载体制备。在大鼠中进行的生物分布研究表明,非极性,亲脂性化合物具有明显的初始脑摄取。谷胱甘肽的体外攻击实验清楚地表明没有发生转螯反应。此外,没有迹象表明Tc(III)会再氧化为Tc(V)物种或高tech酸酯。我们提出这类配合物作为亲脂性〜(99)m Tc或〜(186)Re放射性药物设计的有用工具。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号